NorthWest Biotherapeutics Inc (NWBO)

[chinatown1980]

Here's a thought. Exwan, maybe you could weigh in on this. What if NWBIO stays mum on toplime results, but instead announces that they intend to submit a BLA based on the results. They might know it's a long shot with regulators (say PFS failure due to pseduo progression, confounded OS, etc.), but the underlying intent is to give the impression of solid trial results. This results in some price appreciate from those that gobble up the "good news". Enough that they are able to conduct a sizeable financing and kick off other trials. The expected time for regulator review would even be enough for maybe some preliminary results trickle in to be announced (Direct style stuff) which would create hype to offset soften a final negative decision on the BLA. BLA approval would be icing, worst case is extending duration. What do you think? Doesn't it seem like an NWBIO style maneuver?